Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines
- 26 April 2007
- journal article
- Published by Springer Science and Business Media LLC in Investigational New Drugs
- Vol. 25 (4), 305-312
- https://doi.org/10.1007/s10637-007-9052-9
Abstract
Summary Taurolidine, the active agent of Taurolin®, is a broad spectrum anti-biotic that has been used for over 15 years for the treatment of severe surgical infections. Recently, taurolidine has been shown to possess anti-neoplastic properties in vitro and in vivo against a variety of cancers including ovarian, colon and prostate. In this study we assessed the cytotoxic activity of taurolidine against human osteosarcoma (OS) cell lines and normal human bone cells. Treatment with taurolidine inhibited the growth of all ten osteosarcoma cell lines tested and taurolidine was equally potent against cell lines with and without distinct genetic defects (i.e. p53, Rb). Moreover, taurolidine-induced growth inhibition was found to be associated with a dose dependent increase in the number of apoptotic cells and apoptosis was shown to be caspase-dependent. Taurolidine treatment was also found to inhibit adhesion of OS cell lines. Compared to OS cell lines, normal bone cells in primary culture were found to be less sensitive to the cytotoxic and anti-adhesive effects of taurolidine. These data indicate that taurolidine possesses potent anti-neoplastic activity against osteosarcoma cell lines and may have potential as a novel OS chemotherapeutic agent.Keywords
This publication has 25 references indexed in Scilit:
- Induction of reactive oxygen intermediates—dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidineJournal of Neurosurgery, 2005
- Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in ratsSurgical Endoscopy, 2004
- The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant MesotheliomaClinical Cancer Research, 2004
- Osteosarcoma cell lines display variable individual reactions on wildtype p53 and Rb tumour‐suppressor transgenesThe Journal of Gene Medicine, 2004
- The effect of Taurolidine on adherent and floating subpopulations of melanoma cellsAnti-Cancer Drugs, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Electron and light microscopic observations of bacterial cell surface effects due to taurolidine treatmentLetters in Applied Microbiology, 1987
- Reduced adherence of micro‐organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agentJournal of Applied Bacteriology, 1987
- The mode of antibacterial action of some ‘masked’ formaldehyde compoundsFEBS Letters, 1981
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972